BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Cervical cancer AND AKT1, P31749, RAC-ALPHA, RAC, PRKBA, PKB-ALPHA, PKB, MGC99656, AKT, ENSG00000142208, 207 AND Treatment
391 results:

  • 1. METTL14 decreases FTH1 mRNA stability via m6A methylation to promote sorafenib-induced ferroptosis of cervical cancer.
    Li L; Zeng J; He S; Yang Y; Wang C
    Cancer Biol Ther; 2024 Dec; 25(1):2349429. PubMed ID: 38738555
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Design, synthesis, and biological evaluation of novel benzimidazole derivatives as anti-cervical cancer agents through PI3K/akt/mTOR pathway and tubulin inhibition.
    Li SS; Chen JJ; Zhang MM; Wang WX; Zhang WY; Ma C
    Eur J Med Chem; 2024 May; 271():116425. PubMed ID: 38636129
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Does Preoperative Radiation Therapy Performed for Metastatic Spine cancer at the cervical Spine Increase Perioperative Complications of Anterior cervical Surgery?
    Cho JH; Lee DH; Hwang CJ; Park JW; Park JH; Park S
    Clin Orthop Surg; 2024 Apr; 16(2):286-293. PubMed ID: 38562630
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Transcriptomes of cervical cancer provide novel insights into dysregulated pathways, potential therapeutic targets, and repurposed drugs.
    Tanim MTH; Nath SD; Khan SF; Khan A; Sajib AA
    Cancer Treat Res Commun; 2024; 39():100808. PubMed ID: 38537385
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Circular RNAs and cervical cancer: friends or foes? A landscape on circRNA-mediated regulation of key signaling pathways involved in the onset and progression of HPV-related cervical neoplasms.
    Heydarnia E; Dorostgou Z; Hedayati N; Mousavi V; Yahyazadeh S; Alimohammadi M; Gheibi M; Heidari P; Igder S; Mafi A; Vakili O
    Cell Commun Signal; 2024 Feb; 22(1):107. PubMed ID: 38341592
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Exploring a novel seven-gene marker and mitochondrial gene TMEM38A for predicting cervical cancer radiotherapy sensitivity using machine learning algorithms.
    Wang J; Mou X; Lu H; Jiang H; Xian Y; Wei X; Huang Z; Tang S; Cen H; Dong M; Liang Y; Shi G
    Front Endocrinol (Lausanne); 2023; 14():1302074. PubMed ID: 38327905
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Acetylmelodorinol isolated from Sphaerocoryne affinis seeds inhibits cell proliferation and activates apoptosis on HeLa cells.
    Le-Trung N; Kanaori K; Waku T; Dang TTP; Kamei K
    BMC Complement Med Ther; 2024 Jan; 24(1):59. PubMed ID: 38281034
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Network pharmacology combined with experimental verification to explore the potential mechanism of naringenin in the treatment of cervical cancer.
    Zhou J; Li H; Wu B; Zhu L; Huang Q; Guo Z; He Q; Wang L; Peng X; Guo T
    Sci Rep; 2024 Jan; 14(1):1860. PubMed ID: 38253629
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Four undescribed coumarin derivatives, with ten amides from the roots of Ficus hirta and their cytotoxic activities.
    Ye XS; Tian WJ; Wang GH; Hu LJ; Leng CL; Sun BL; Liu W; Shu XJ; Chen HF
    Bioorg Chem; 2024 Mar; 144():107116. PubMed ID: 38237391
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. DHCR7 promotes lymph node metastasis in cervical cancer through cholesterol reprogramming-mediated activation of the KANK4/PI3K/akt axis and VEGF-C secretion.
    Mei X; Xiong J; Liu J; Huang A; Zhu D; Huang Y; Wang H
    Cancer Lett; 2024 Mar; 584():216609. PubMed ID: 38211648
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Phase I Study of mTORC1/2 Inhibitor Sapanisertib (CB-228/TAK-228) in Combination with Metformin in Patients with mTOR/akt/PI3K Pathway Alterations and Advanced Solid Malignancies.
    Subbiah V; Coleman N; Piha-Paul SA; Tsimberidou AM; Janku F; Rodon J; Pant S; Dumbrava EEI; Fu S; Hong DS; Zhang S; Sun M; Jiang Y; Roszik J; Song J; Yuan Y; Meric-Bernstam F; Naing A
    Cancer Res Commun; 2024 Feb; 4(2):378-387. PubMed ID: 38126764
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. The effects of HPV oncoproteins on host communication networks: Therapeutic connotations.
    Skelin J; Luk HY; Butorac D; Boon SS; Tomaić V
    J Med Virol; 2023 Dec; 95(12):e29315. PubMed ID: 38115222
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. HPV E6/E7: insights into their regulatory role and mechanism in signaling pathways in HPV-associated tumor.
    Peng Q; Wang L; Zuo L; Gao S; Jiang X; Han Y; Lin J; Peng M; Wu N; Tang Y; Tian H; Zhou Y; Liao Q
    Cancer Gene Ther; 2024 Jan; 31(1):9-17. PubMed ID: 38102462
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. TRIM11 regulated by m6A modification promotes the progression of cervical cancer by PHLPP1 ubiquitination.
    Zhang P; Tang Y; Zhao J; Yang J; Chen Y; Gong Y; Meng S; Shu C
    Neoplasma; 2023 Oct; 70(5):659-669. PubMed ID: 38053376
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Design, synthesis and bioevaluation of novel prenylated chalcones derivatives as potential antitumor agents.
    Yu J; Wang X; Cheng S; Zeng X; Wan X; Wei S; Xu B; Luo H; Meng X
    Eur J Pharm Sci; 2024 Jan; 192():106660. PubMed ID: 38052256
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Comprehensive exploration of Biochanin A as an oncotherapeutics potential in the treatment of multivarious cancers with molecular insights.
    Sohel M
    Phytother Res; 2024 Feb; 38(2):489-506. PubMed ID: 37905329
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. [Risk factor analysis of lymph node metastasis in endometrial carcinoma combined with molecular types].
    Li LL; Li H; Li J; Zhang XB; Wang ZQ; Shen DH; Wang JL
    Zhonghua Fu Chan Ke Za Zhi; 2023 Oct; 58(10):733-741. PubMed ID: 37849254
    [No Abstract]    [Full Text] [Related]  

  • 18. The clinical relevance of OSM in inflammatory diseases: a comprehensive review.
    Wolf CL; Pruett C; Lighter D; Jorcyk CL
    Front Immunol; 2023; 14():1239732. PubMed ID: 37841259
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Transglutaminase 3 suppresses proliferation and cisplatin resistance of cervical cancer cells by inactivation of the PI3K/akt pathway.
    Chen R; Fang T; Liu N; Shi X; Wang J; Yu H
    Naunyn Schmiedebergs Arch Pharmacol; 2024 Apr; 397(4):2269-2280. PubMed ID: 37812238
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Prevalence and Prognostic Significance of PIK3CA Mutation and CNV Status and Phosphorylated akt Expression in Patients With cervical cancer Treated With Primary Surgery.
    Martell K; McIntyre JB; Abedin T; Kornaga EN; Chan AMY; Enwere E; Köbel M; Dean ML; Phan T; Ghatage P; Lees-Miller SP; Doll CM
    Int J Gynecol Pathol; 2024 Mar; 43(2):158-170. PubMed ID: 37668363
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 20.